Opendata, web and dolomites
AGENZIA ITALIANA DEL FARMACO (Italy): list of projects
The following table shows the list of Horizon 2020 projects developed by "AGENZIA ITALIANA DEL FARMACO". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | ADAPT-SMART | H2020-EU.3.1.7.13. | participant | 28˙000.00 | 2015-07-01 | 940 |
| 2 | PARADIGM | H2020-EU.3.1.7. | participant | 50˙000.00 | 2018-03-01 | 775 |
| 3 | STARS | H2020-EU.3.1.6. | participant | 57˙000.00 | 2019-01-01 | 477 |
| totale | 135˙000.00 | |||||
Network analysis
This organization collaborated with partners in 22 countries.
ADAPT-SMART
Within the project ADAPT-SMART this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | CH | SHIRE | SHIRE INTERNATIONAL GMBH (PRC) |
| participant | UK | AbbVie | AbbVie Ltd (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | FR | Lysogene | LYSOGENE (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | UK | Astellas | ASTELLAS PHARMA EUROPE LTD (PRC) |
| participant | NL | ZIN | ZORGINSTITUUT NEDERLAND (PUB) |
| participant | FR | IPSEN | IPSEN INNOVATION SAS (PRC) |
| participant | FR | HAS | HAUTE AUTORITE DE SANTE (PUB) |
| participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | UK | NICE | NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (PUB) |
| participant | US | BMS | BRISTOL-MYERS SQUIBB COMPANY CORP (PRC) |
| participant | BE | Amgen | AMGEN (PRC) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | UK | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
| coordinator | NL | LYGATURE | STICHTING LYGATURE (OTH) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | DE | Bayer | Bayer Pharma AG (PRC) |
| participant | US | MIT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (HES) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | DK | DHMA | SUNDHEDSSTYRELSEN (PUB) |
| participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
PARADIGM
Within the project PARADIGM this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | BE | Alexion | ALEXION SERVICES EUROPE SPRL (PRC) |
| participant | CA | HTAi | HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY (OTH) |
| participant | BE | Synergist | THE SYNERGIST (OTH) |
| participant | UK | ABPI | THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY (OTH) |
| participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
| participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
| participant | UK | Amgen | AMGEN LIMITED (PRC) |
| participant | BE | EFPIA | FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES (OTH) |
| participant | NL | STICHTING VU | STICHTING VU (HES) |
| participant | DE | VFA | VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV (OTH) |
| participant | FR | EURORDIS | EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION (OTH) |
| participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
| participant | UK | Covance | COVANCE LABORATORIES LTD (PRC) |
| participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
| participant | ES | SYNAPSE | SYNAPSE RESEARCH MANAGEMENT PARTNERS SL (PRC) |
| participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
| participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
| participant | LU | AE | ALZHEIMER EUROPE (OTH) |
| participant | UK | PFIZER | PFIZER LIMITED (PRC) |
| participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
| participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
| participant | ES | IACS | INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD (REC) |
| participant | DE | EATG | EUROPEAN AIDS TREATMENT GROUP EV (OTH) |
| coordinator | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
| participant | ES | FSJD | FUNDACIO SANT JOAN DE DEU (REC) |
| participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
| participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
| participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
| participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
| participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
| participant | BE | EFGCP | EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE (OTH) |
| participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
| participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
STARS
Within the project STARS this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | LV | SAMLV | ZALU VALSTS AGENTURA (PUB) |
| participant | LT | VVKT | VALSTYBINE VAISTU KONTROLES TARNYBAPRIE LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJOS (PUB) |
| participant | UK | MHRA | MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (PUB) |
| participant | FI | FIMEA | LAAKEALAN TURVALLISUUS-JA KEHITTAMISKESKUS (REC) |
| participant | PL | URPLWMiPB | URZAD REJESTRACJI PRODUKTOW LECZNICZYCH, WYROBOW MEDYCZNYCH I PRODUKTOW BIOBOJCZYCH (PUB) |
| participant | CZ | SÚKL | STATNI USTAV PRO KONTROLU LECIV (PUB) |
| participant | IE | HPRA | HEALTH PRODUCTS REGULATORY AUTHORITY (PUB) |
| participant | NL | MEB | AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN (PUB) |
| participant | FR | ANSM | AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE (PUB) |
| participant | HU | OGYEI | ORSZAGOS GYOGYSZERESZETI ES ELELMEZES-EGESZSEGUGYI INTEZET (REC) |
| participant | BE | AFMPS | FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS (REC) |
| participant | PT | INFARMED | INFARMED - AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP (PUB) |
| participant | MT | MA | THE MEDICINES AUTHORITY (PUB) |
| participant | NL | EMA | THE EUROPEAN MEDICINES AGENCY (PUB) |
| participant | DE | PEI | BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL (PUB) |
| participant | AT | AGES | OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT GMBH (REC) |
| coordinator | DE | BfArM | BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE (PUB) |
| participant | SE | MPA | LAKEMEDELSVERKET (PUB) |
| participant | ES | AEMPS | AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (PUB) |
| participant | DE | DLR | DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV (REC) |